Chemed Other Non-Current Liabilities 2010-2025 | CHE

Chemed other non-current liabilities from 2010 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Chemed other non-current liabilities for the quarter ending March 31, 2025 were $0.013B, a 1.54% increase year-over-year.
  • Chemed other non-current liabilities for 2024 were $0.013B, a 2.81% increase from 2023.
  • Chemed other non-current liabilities for 2023 were $0.013B, a 7.14% increase from 2022.
  • Chemed other non-current liabilities for 2022 were $0.012B, a 25.87% increase from 2021.
Chemed Annual Other Non-Current Liabilities
(Millions of US $)
2024 $13
2023 $13
2022 $12
2021 $10
2020 $26
2019 $8
2018 $17
2017 $17
2016 $16
2015 $13
2014 $13
2013 $11
2012 $11
2011 $10
2010 $7
2009 $5
Chemed Quarterly Other Non-Current Liabilities
(Millions of US $)
2025-03-31 $13
2024-12-31 $13
2024-09-30 $13
2024-06-30 $13
2024-03-31 $13
2023-12-31 $13
2023-09-30 $13
2023-06-30 $13
2023-03-31 $13
2022-12-31 $12
2022-09-30 $12
2022-06-30 $11
2022-03-31 $10
2021-12-31 $10
2021-09-30 $28
2021-06-30 $27
2021-03-31 $27
2020-12-31 $26
2020-09-30 $31
2020-06-30 $19
2020-03-31 $8
2019-12-31 $8
2019-09-30 $8
2019-06-30 $8
2019-03-31 $8
2018-12-31 $17
2018-09-30 $17
2018-06-30 $17
2018-03-31 $17
2017-12-31 $17
2017-09-30 $16
2017-06-30 $16
2017-03-31 $16
2016-12-31 $16
2016-09-30 $15
2016-06-30 $15
2016-03-31 $14
2015-12-31 $13
2015-09-30 $13
2015-06-30 $13
2015-03-31 $13
2014-12-31 $13
2014-09-30 $11
2014-06-30 $11
2014-03-31 $11
2013-12-31 $11
2013-09-30 $11
2013-06-30 $12
2013-03-31 $12
2012-12-31 $11
2012-09-30 $11
2012-06-30 $12
2012-03-31 $12
2011-12-31 $10
2011-09-30 $10
2011-06-30 $7
2011-03-31 $6
2010-12-31 $7
2010-09-30 $7
2010-06-30 $6
2010-03-31 $5
2009-12-31 $5
2009-09-30 $4
2009-06-30 $4
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.214B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.936B 18.66
Encompass Health (EHC) United States $11.956B 25.34
DaVita (DVA) United States $10.458B 14.70
Elanco Animal Health (ELAN) United States $6.293B 13.48
Option Care Health (OPCH) United States $5.245B 23.38
RadNet (RDNT) United States $4.259B 270.33
Amedisys (AMED) United States $3.071B 20.65
LifeStance Health (LFST) United States $2.189B 0.00
Addus HomeCare (ADUS) United States $2.052B 22.53
Astrana Health (ASTH) United States $1.372B 33.99
U.S Physical Therapy (USPH) United States $1.145B 29.57
Aveanna Healthcare Holdings (AVAH) United States $1.044B 59.44
Pennant (PNTG) United States $0.967B 35.52
Atai Life Sciences (ATAI) Germany $0.405B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.045B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00